Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5076
CALL
Kimbell Royalty Partners
KRP
$1.52B
| $3.06M | ﹤0.01% |
260,000
+93,800
| +56% | +$1.2M |
|
5077
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$191M
| $3.06M | ﹤0.01% |
82,230
+46,092
| +128% | +$1.6M |
|
5078
First Bancorp
FBNC
$2.74B
| $3.06M | ﹤0.01% |
60,162
+14,771
| +33% | +$749K |
|
5079
Edgewise Therapeutics
EWTX
$4.8B
| $3.05M | ﹤0.01% |
123,097
+100,780
| +452% | +$2.02M |
|
|
BIOA
5080
BioAge Labs
BIOA
$487M
| $3.05M | ﹤0.01% |
230,543
+116,480
| +102% | +$1.03M |
|
5081
Cars.com
CARS
$663M
| $3.05M | ﹤0.01% |
249,871
+68,404
| +38% | +$795K |
|
5082
Perella Weinberg Partners
PWP
$1.29B
| $3.04M | ﹤0.01% |
175,998
-125,273
| -42% | -$2.34M |
|
5083
MiMedx Group
MDXG
$622M
| $3.04M | ﹤0.01% |
449,662
+312,503
| +228% | +$2.19M |
|
5084
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.45B
| $3.04M | ﹤0.01% |
+29,751
| New | +$3.05M |
|
5085
Glaukos
GKOS
$10.9B
| $3.04M | ﹤0.01% |
26,956
-28,984
| -52% | -$2.77M |
|
5086
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $3.04M | ﹤0.01% |
56,600
+9,400
| +20% | +$511K |
|
5087
CALL
H&R Block
HRB
$6.83B
| $3.04M | ﹤0.01% |
69,800
+35,800
| +105% | +$1.67M |
|
5088
PUT
Herc Holdings
HRI
$5.8B
| $3.04M | ﹤0.01% |
20,500
-20,196
| -50% | -$2.77M |
|
5089
Global Ship Lease
GSL
$1.52B
| $3.04M | ﹤0.01% |
86,746
-110,132
| -56% | -$3.58M |
|
5090
Dorchester Minerals
DMLP
$1.36B
| $3.04M | ﹤0.01% |
135,935
+107,641
| +380% | +$2.52M |
|
5091
Miller Industries
MLR
$645M
| $3.04M | ﹤0.01% |
81,318
+71,540
| +732% | +$2.78M |
|
5092
CALL
ARK Blockchain & Fintech Innovation ETF
ARKF
$771M
| $3.04M | ﹤0.01% |
63,800
+14,100
| +28% | +$736K |
|
|
5093
CALL
Glaukos
GKOS
$10.9B
| $3.04M | ﹤0.01% |
26,900
-15,500
| -37% | -$1.48M |
|
|
ROBN
5094
PUT
T-Rex 2X Long HOOD Daily Target ETF
ROBN
$101M
| $3.04M | ﹤0.01% |
56,100
-276,300
| -83% | -$22.8M |
|
5095
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$47.3M
| $3.04M | ﹤0.01% |
63,190
+15,402
| +32% | +$741K |
|
5096
PUT
Curtiss-Wright
CW
$25.8B
| $3.03M | ﹤0.01% |
5,500
+1,600
| +41% | +$892K |
|
5097
ARK Space & Defense Innovation ETF
ARKX
$865M
| $3.03M | ﹤0.01% |
104,622
-15,315
| -13% | -$447K |
|
5098
CALL
Silicon Motion
SIMO
$9.12B
| $3.03M | ﹤0.01% |
32,700
-4,900
| -13% | -$450K |
|
5099
Fidelity Electric Vehicles and Future Transportation ETF
FDRV
$27.3M
| $3.03M | ﹤0.01% |
185,006
+132,673
| +254% | +$2.25M |
|
5100
Copa Holdings
CPA
$6.14B
| $3.03M | ﹤0.01% |
25,120
+21,461
| +587% | +$2.63M |
|
Similar funds
Ken Griffin's Q4 2025 Portfolio in Review
As of Q4 2025, Ken Griffin held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Ken Griffin added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Ken Griffin's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Ken Griffin fully exited WEX in Q4 2025, selling an estimated $131M.
- Ken Griffin's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Ken Griffin opened 2,078 new positions and closed 2,191 in Q4 2025.
- Ken Griffin's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.